RecruitingNot ApplicableNCT07710547

TCP-600 Supplementation and Performance Response in Professional Football Players

External Validation and Extension of Physical, Recovery, and Perceptual-Cognitive Responder Profiles After Phosphatidylserine-Containing Taurine-Caffeine Supplementation in Professional Football Players: A Randomized, Double-Blind, Placebo-Controlled Trial


Sponsor

Vizja University in Warsaw

Enrollment

65 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will examine whether a 28-day supplementation protocol containing taurine, caffeine, and phosphatidylserine can help professional male football players maintain physical performance, cognitive function, recovery-related readiness, and selected football-specific perceptual-cognitive performance. Participants will be randomly assigned to receive either placebo or a phosphatidylserine-containing multi-ingredient supplement. Before and after the supplementation period, players will complete non-invasive assessments such as sprint testing, reaction-time testing, heart rate variability monitoring, wellness/readiness questionnaires, mental-fatigue measures, and selected football-specific perceptual-cognitive tasks where available. The study is designed as an external validation and extension of responder profiles derived from previous randomized controlled trials. Data from previous trials and this validation cohort will be used to examine whether baseline physical, cognitive, autonomic, fatigue-related, recovery-related, or perceptual-cognitive characteristics can predict which players are most likely to benefit from phosphatidylserine-containing multi-ingredient supplementation.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 37 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Caffeine, Phosphatidylserine, and others for people with athletic performance, cognitive fatigue, and other related conditions. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPlacebo

Matching placebo capsules administered orally once daily for 28 consecutive days. The placebo was matched to the active supplements in appearance, number, packaging, and administration schedule.

DIETARY_SUPPLEMENTTaurine

Taurine 1500 mg/day administered orally once daily in capsules for 28 consecutive days.

DIETARY_SUPPLEMENTCaffeine

Anhydrous caffeine 200 mg/day administered orally once daily in capsules for 28 consecutive days.

DIETARY_SUPPLEMENTPhosphatidylserine

Phosphatidylserine 600 mg/day administered orally once daily in capsules for 28 consecutive days.


Locations(3)

Professional Football Training Center

Krakow, Poland

Professional Football Training Center

Lodz, Poland

Professional Football Training Center

Warsaw, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07710547


Related Trials